{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:23:23Z","timestamp":1781033003903,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The infection rates with SARS-CoV 2 virus, known since 2019, are currently significantly weakened in their dynamics. Nevertheless, COVID 19 is still a common disease, which in most cases is overcome quite well and can be treated by the general practitioner. Despite an initially uncomplicated disease progression, the long-term consequences can be considerable. Symptoms persisting over a period of more than 12\u00a0weeks after infection are summarized as Post-COVID (PC) syndrome. The aim of this study is to document the symptom expression in PC patients in the outpatient setting, with a major focus on limitations in daily life and consequences for mental health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This survey is part of a prospective European collaborative study with the German cohort having been slightly extended and evaluated separately. Data collection was performed by telephone interviews of adult SARS CoV 2 positive patients using standardized questionnaires (38 open and 6 closed questions). After an inclusion interview, follow-up interviews were conducted every 4\u00a0weeks over a period of 6\u00a0months. Participants were recruited in collaboration with the local health department (Wuerzburg, Germany).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty participants were recruited in April and May 2021. After 12\u00a0weeks (PC cutoff), 48.3% still reported symptoms related to SARS-CoV-2 infection. The most commonly reported symptoms were fatigue\/tiredness (33.3%), reduced concentration (26.7%), and shortness of breath (23.3%). One-quarter of respondents reported impaired functioning, with the most common daily limitations being sports (28.3%), work (25.0%), and social life (15.0%). At 6\u00a0months, 21.6% of respondents experienced anxiety and 11.6% reported depressive symptoms. Overall, 40.0% of respondents were concerned that their health would deteriorate again or not fully normalize because of COVID-19. Over two-thirds (70.0%) visited a physician during the course of the study because of COVID-19, 73.8% of whom visited their general practitioner.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PC in outpatient care appears to be a complex and multifaceted condition that not only presents with physical symptoms, but also has a significant impact on mental health and daily life. Although the complexity of the condition is not yet fully understood, our findings suggest that it presents long-term challenges, particularly in outpatient care. Further research, particularly in larger and more diverse cohorts, is needed to confirm these observations. Routine screening for psychosocial comorbidities could be a valuable approach to identify supportive interventions that may help to reduce the risk of chronification and\/or somatization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12875-025-02784-3","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T15:02:03Z","timestamp":1743692523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lingering symptoms in non-hospitalized patients with COVID-19 \u2013 a prospective survey study of symptom expression and effects on mental health in Germany"],"prefix":"10.1186","volume":"26","author":[{"given":"J\u00f6rn","family":"Rohde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Bundschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Kau\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Simmenroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"2784_CR1","doi-asserted-by":"crossref","unstructured":"Has\u00f6ks\u00fcz M, Kili\u00e7 S, Sara\u00e7 F. Coronaviruses and SARS-COV-2. Turk J Med Sci. 2020;50(Si-1):549\u201356.","DOI":"10.3906\/sag-2004-127"},{"key":"2784_CR2","unstructured":"World Health Organization. WHO Health Emergency Dashboard Pages: 1 Type of Article: Report of an institution.\u00a02023. https:\/\/covid19.who.int\/explorer."},{"key":"2784_CR3","unstructured":"Robert Koch Institut. COVID-19-Dashboard 2023 [Available from: https:\/\/experience.arcgis.com\/experience\/478220a4c454480e823b17327b2bf1d4."},{"issue":"15","key":"2784_CR4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","volume":"69","author":"S Garg","year":"2020","unstructured":"Garg S, Kim L, Whitaker M, O\u2019Halloran A, Cummings C, Holstein R, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1\u201330, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458\u201364.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2784_CR5","doi-asserted-by":"crossref","first-page":"101762","DOI":"10.1016\/j.eclinm.2022.101762","volume":"55","author":"LL O\u2019Mahoney","year":"2023","unstructured":"O\u2019Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762.","journal-title":"EClinicalMedicine"},{"key":"2784_CR6","doi-asserted-by":"publisher","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. WHO clinical case definition working Group on post-COVID-19 condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102\u20137. https:\/\/doi.org\/10.1016\/S1473-3099(21)00703-9.","DOI":"10.1016\/S1473-3099(21)00703-9"},{"key":"2784_CR7","doi-asserted-by":"crossref","first-page":"100724","DOI":"10.1016\/j.lanepe.2023.100724","volume":"33","author":"L Mateu","year":"2023","unstructured":"Mateu L, Tebe C, Loste C, Santos JR, Llad\u00f3s G, L\u00f3pez C, et al. Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study. Lancet Reg Health Eur. 2023;33:100724.","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"2784_CR8","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","volume":"30","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A, et al. Long COVID science, research and policy. Nat Med. 2024;30(8):2148\u201364.","journal-title":"Nat Med"},{"issue":"7","key":"2784_CR9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s40263-022-00931-3","volume":"36","author":"MG Mazza","year":"2022","unstructured":"Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment. CNS Drugs. 2022;36(7):681\u2013702.","journal-title":"CNS Drugs"},{"key":"2784_CR10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","volume":"101","author":"F Ceban","year":"2022","unstructured":"Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93\u2013135.","journal-title":"Brain Behav Immun"},{"issue":"5","key":"2784_CR11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmi.2022.01.014","volume":"28","author":"MS Alkodaymi","year":"2022","unstructured":"Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657\u201366.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"2784_CR12","first-page":"175","volume":"119","author":"K Lackermair","year":"2022","unstructured":"Lackermair K, Wilhelm K, William F, Grzanna N, Lehmann E, Sams L, et al. The Prevalence of Persistent Symptoms After COVID-19 Disease. Dtsch Arztebl Int. 2022;119(10):175\u20136.","journal-title":"Dtsch Arztebl Int"},{"issue":"10","key":"2784_CR13","first-page":"167","volume":"119","author":"C F\u00f6rster","year":"2022","unstructured":"F\u00f6rster C, Colombo MG, Wetzel A-J, Martus P, Joos S. Persistierende Symptome nach COVID-19. Dtsch Arztebl International. 2022;119(10):167\u201374.","journal-title":"Dtsch Arztebl International"},{"issue":"2","key":"2784_CR14","doi-asserted-by":"crossref","first-page":"2154074","DOI":"10.1080\/13814788.2022.2154074","volume":"29","author":"K Hedin","year":"2023","unstructured":"Hedin K, van der Velden AW, Hansen MP, Moberg AB, Balan A, Bruno P, et al. Initial symptoms and three months follow-up after acute COVID-19 in outpatients: An international prospective cohort study. Eur J Gen Pract. 2023;29(2):2154074.","journal-title":"Eur J Gen Pract"},{"issue":"1","key":"2784_CR15","doi-asserted-by":"crossref","first-page":"14921","DOI":"10.1038\/s41598-024-65382-w","volume":"14","author":"C Roncero","year":"2024","unstructured":"Roncero C, D\u00edaz-Trejo S, \u00c1lvarez-Lamas E, Garc\u00eda-Ull\u00e1n L, Bersab\u00e9-P\u00e9rez M, Benito-S\u00e1nchez JA, et al. Follow-up of telemedicine mental health interventions amid COVID-19 pandemic. Sci Rep. 2024;14(1):14921.","journal-title":"Sci Rep"},{"key":"2784_CR16","doi-asserted-by":"publisher","unstructured":"Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, Razani B, Mwangi J, Asadi-Pooya AA, Malekmakan L Bastani B. Long COVID, a comprehensive systematic scoping review. Infection.\u00a02021;49(6):1163-86. https:\/\/doi.org\/10.1007\/s15010-021-01666-x.","DOI":"10.1007\/s15010-021-01666-x"},{"key":"2784_CR17","unstructured":"Robert Koch Institut. Besorgniserregende SARS-CoV-2-Virusvarianten (VOC) 2023 [Available from: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Virusvariante.html."},{"issue":"10","key":"2784_CR18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"key":"2784_CR19","unstructured":"IBM Corp. IBM SPSS Statistics for Windows. Released 2020. Version 27.0. Armonk, NY: IBM Corp."},{"key":"2784_CR20","doi-asserted-by":"crossref","first-page":"100122","DOI":"10.1016\/j.lanepe.2021.100122","volume":"6","author":"M Augustin","year":"2021","unstructured":"Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Regional Health Eur. 2021;6:100122.","journal-title":"Lancet Regional Health Eur"},{"key":"2784_CR21","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Palacios-Ce\u00f1a D, G\u00f3mez-Mayordomo V, Cuadrado ML, Florencio LL. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int J Environ Res Public Health. 2021;18(5):2621. https:\/\/doi.org\/10.3390\/ijerph18052621.","DOI":"10.3390\/ijerph18052621"},{"key":"2784_CR22","unstructured":"World Health Organization. Coronavirus disease (COVID-19): Post COVID-19 condition 2021 [Available from: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/coronavirus-disease-(covid-19)-post-covid-19-condition."},{"issue":"4","key":"2784_CR23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10096-022-04417-4","volume":"41","author":"NN Nguyen","year":"2022","unstructured":"Nguyen NN, Hoang VT, Dao TL, Dudouet P, Eldin C, Gautret P. Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review. Eur J Clin Microbiol Infect Dis. 2022;41(4):515\u201345.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2784_CR24","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, Arendt-Nielsen L, Torres-Macho J, Plaza-Manzano G. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature. Viruses. 2022;14(12):2629. https:\/\/doi.org\/10.3390\/v14122629.","DOI":"10.3390\/v14122629"},{"issue":"5","key":"2784_CR25","doi-asserted-by":"crossref","first-page":"104688","DOI":"10.1016\/j.idnow.2023.104688","volume":"53","author":"A Hern\u00e1ndez-Aceituno","year":"2023","unstructured":"Hern\u00e1ndez-Aceituno A, Garc\u00eda-Hern\u00e1ndez A, Larumbe-Zabala E. COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants. Infect Dis Now. 2023;53(5):104688.","journal-title":"Infect Dis Now"},{"key":"2784_CR26","doi-asserted-by":"publisher","unstructured":"Notarte KI, de Oliveira MHS, Peligro PJ, Velasco JV, Macaranas I, Ver AT, Pangilinan FC, Pastrana A, Goldrich N, Kavteladze D, Gellaco MML, Liu J, Lippi G, Henry BM, Fern\u00e1ndez-de-Las-Pe\u00f1as C. age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: A systematic review and meta-analysis. J Clin Med. 2022;11(24):7314. https:\/\/doi.org\/10.3390\/jcm11247314.","DOI":"10.3390\/jcm11247314"},{"issue":"8","key":"2784_CR27","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706\u201314.","journal-title":"Nat Med"},{"issue":"3","key":"2784_CR28","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1093\/cid\/ciab103","volume":"73","author":"KB Jacobson","year":"2021","unstructured":"Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, et al. Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic. Clin Infect Dis. 2021;73(3):e826\u20139.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2784_CR29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353\u201365.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"2784_CR30","doi-asserted-by":"crossref","first-page":"e005427","DOI":"10.1136\/bmjgh-2021-005427","volume":"6","author":"M Michelen","year":"2021","unstructured":"Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427.","journal-title":"BMJ Glob Health"},{"key":"2784_CR31","doi-asserted-by":"publisher","unstructured":"Andr\u00e9s-Olivera P, Garc\u00eda-Aparicio J, Lozano L\u00f3pez MT, Benito S\u00e1nchez JA, Mart\u00edn C, Maci\u00e1-Casas A, Gonz\u00e1lez-S\u00e1nchez A, Marcos M, Roncero C. Impact on sleep quality, mood, anxiety, and personal satisfaction of doctors assigned to COVID-19 units. Int J Environ Res Public Health. 2022;19(5):2712. https:\/\/doi.org\/10.3390\/ijerph19052712.","DOI":"10.3390\/ijerph19052712"},{"key":"2784_CR32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbi.2021.07.018","volume":"97","author":"TM Schou","year":"2021","unstructured":"Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review. Brain Behav Immun. 2021;97:328\u201348.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"2784_CR33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/PSY.0000000000000954","volume":"83","author":"WJ Kop","year":"2021","unstructured":"Kop WJ. Biopsychosocial Processes of Health and Disease During the COVID-19 Pandemic. Psychosom Med. 2021;83(4):304\u20138.","journal-title":"Psychosom Med"},{"issue":"1","key":"2784_CR34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s15006-021-0540-1","volume":"164","author":"S Bisenius","year":"2022","unstructured":"Bisenius S, Kersting A. Psychosomatic aspects of Long COVID. MMW Fortschr Med. 2022;164(1):40\u20131.","journal-title":"MMW Fortschr Med"},{"issue":"2","key":"2784_CR35","doi-asserted-by":"crossref","first-page":"e14037","DOI":"10.1111\/hex.14037","volume":"27","author":"D Clutterbuck","year":"2024","unstructured":"Clutterbuck D, Ramasawmy M, Pantelic M, Hayer J, Begum F, Faghy M, et al. Barriers to healthcare access and experiences of stigma: Findings from a coproduced Long Covid case-finding study. Health Expect. 2024;27(2):e14037.","journal-title":"Health Expect"},{"key":"2784_CR36","doi-asserted-by":"crossref","first-page":"1085988","DOI":"10.3389\/fmed.2023.1085988","volume":"10","author":"YJ Lai","year":"2023","unstructured":"Lai YJ, Liu SH, Manachevakul S, Lee TA, Kuo CT, Bello D. Biomarkers in long COVID-19: A systematic review. Front Med (Lausanne). 2023;10:1085988.","journal-title":"Front Med (Lausanne)"},{"key":"2784_CR37","unstructured":"Techniker Krankenkasse. Entgeltfortzahlung im Krankheitsfall 01\/2023 [Available from: https:\/\/www.tk.de\/resource\/blob\/2033356\/1d5c5d15bb6203c57130375abd9ede6c\/beratungsblatt-entgeltfortzahlung-bei-krankheit-data.pdf."},{"key":"2784_CR38","unstructured":"Grobe TG, Sven B. Zwei Jahre Coronapandemie: Wie geht es Deutschlands Besch\u00e4ftigten? Gesundheitsreport Techniker Krankenkasse. 2022;2:62. https:\/\/www.tk.de\/resource\/blob\/2130932\/70a0d93d19f6444f06310379441bd046\/gesundheitsreport-2022-data.pdf."},{"issue":"1","key":"2784_CR39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/s12913-023-09601-6","volume":"23","author":"A Gandjour","year":"2023","unstructured":"Gandjour A. Long COVID: Costs for the German economy and health care and pension system. BMC Health Serv Res. 2023;23(1):641.","journal-title":"BMC Health Serv Res"},{"key":"2784_CR40","unstructured":"Robert Koch Institut. Bericht zu Virusvarianten von SARS-CoV-2 in Deutschland. Bericht zu Virusvarianten von SARS-CoV-2 in Deutschland. 2021(9):14. Bericht. https:\/\/www.rki.de\/DE\/Themen\/Infektionskrankheiten\/Infektionskrankheiten-A-Z\/C\/COVID-19-Pandemie\/DESH\/Bericht_VOC_2021-05-12.pdf?__blob=publicationFile&v=1."},{"issue":"5","key":"2784_CR41","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/irv.12982","volume":"16","author":"JO Wrenn","year":"2022","unstructured":"Wrenn JO, Pakala SB, Vestal G, Shilts MH, Brown HM, Bowen SM, et al. COVID-19 severity from Omicron and Delta SARS-CoV-2 variants. Influenza Other Respir Viruses. 2022;16(5):832\u20136.","journal-title":"Influenza Other Respir Viruses"},{"issue":"10343","key":"2784_CR42","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0140-6736(22)00941-2","volume":"399","author":"M Antonelli","year":"2022","unstructured":"Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263\u20134.","journal-title":"Lancet"},{"key":"2784_CR43","doi-asserted-by":"crossref","first-page":"e069676","DOI":"10.1136\/bmj-2021-069676","volume":"377","author":"D Ayoubkhani","year":"2022","unstructured":"Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676.","journal-title":"BMJ"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-02784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-025-02784-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-02784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T15:03:23Z","timestamp":1743692603000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-025-02784-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2784"],"URL":"https:\/\/doi.org\/10.1186\/s12875-025-02784-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3711282\/v1","asserted-by":"object"}]},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prior to participation in the study, each patient was informed verbally by a physician and by letter about the study procedure. Subsequently, an informed consent form was signed by each patient. To ensure pseudonymized and later anonymized documentation, each patient was assigned an individual study identification number. Participation in the survey was voluntary. All steps in this study were performed in accordance with the Declaration of Helsinki. The study was reviewed and approved by the Ethics Committee of the University of Wuerzburg (4\/21-me).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}